US Patent Issued to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY on July 14 for "Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,845, issued on July 14, was assigned to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY Co. LTD. (Shenzhen, China).

"Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor" was invented by Sheng Su (Shanghai), Yunfu Luo (Shanghai) and Guoli Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a crystal form of a triazolopyridine-substituted indazole compound and a preparation method therefor; and specifically disclosed are a crystal form of a compound as represented by formula (I) and a preparation method therefor."

The patent was filed on June 23, 2022, under Application No. 18/574,378.

*For f...